patent, genetics & genomics

Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  

LabCorp might be able to charge a licensing fee to any scientists who wish to sequence the gene HOMER1 in people who may have autism.

Hurricanes, protests, and lifesaving genetic engineering: our picks for the biggest stories of the year

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

Caribou Biosciences receives a patent related to the gene-editing technology.

A challenge to the first CRISPR patent just got teeth.

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

Researchers stake their proprietary claim on the genome-editing technique.

The Broad Institute has succeeded in getting the first patent for the hot new genome-editing technique.

The importance of smORFs; America Invents Act and innovation in biotech; birds adjust their behavior to avoid cars; in defense of fundamental science

A decision will not be reached until later in the year, but the United States’ top justices appear to be inclined to rule against the validity of patenting human genes.

2012 saw the birth of a handful of non-invasive genetic prenatal tests, but the young industry faces growing pains as legal and ethical questions loom. 

Four companies who have developed noninvasive genetic prenatal tests are fighting over who has the patent rights to the new and revolutionary techniques.

Legal battles over gene patents and uncooperative patent holders threaten the widespread implementation of personalized medicine.